# Azora Therapeutics, Inc. (DE): Form 8-K, filed Mar 4, 2025

- Company: [Azora Therapeutics, Inc. (DE)](/companies/adil.md) (CIK 1513525)
- Form: 8-K
- Filed: 2025-03-04
- Accepted by EDGAR: Mar 4, 2025, 08:57 ET
- Period: 2025-03-04
- Accession: 0001213900-25-019779
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025019779/ea0232881-8k_adial.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1513525/000121390025019779/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1513525/000121390025019779/ea0232881-8k_adial.htm

Filed Mar 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-019779. Last ingested by Listed: Nov 4, 2026, 18:38 ET. No prices; not investment advice.